Editors Guidelines
Guidance for editors overseeing bioinformatics and diabetes submissions.
Journal at a Glance
ISSN: 2374-9431
DOI Prefix: 10.14302/issn.2374-9431
License: CC BY 4.0
Peer reviewed open access journal
Scope Alignment
Bioinformatics, computational genomics, multi-omics integration, systems biology, clinical informatics, and data driven insights for diabetes and metabolic disease. We prioritize reproducible analytics.
Publishing Model
Open access, single blind peer review, and rapid publication after acceptance and production checks. Metadata validation and DOI registration are included.
Editors guide the peer review process and ensure that published research meets JBD standards for methodological rigor and clinical relevance. Editors also help maintain transparency and fairness in manuscript decisions.
Initial Assessment
Confirm scope fit and basic compliance.
Reviewer Selection
Identify qualified reviewers in bioinformatics and diabetes.
Decision Making
Evaluate reviews and determine next steps.
Author Communication
Provide clear guidance and expectations.
- Sound data provenance and ethical compliance
- Reproducible computational methods
- Clear interpretation of diabetes related findings
- Adequate validation and benchmarking
Editors must disclose conflicts of interest and recuse themselves when necessary. Appeals are handled transparently and may involve additional editorial review.
- Confirm scope alignment and data availability
- Check ethical approvals and consent statements
- Verify reviewer expertise and balance
- Ensure decisions are supported by evidence
- Confirm reviewer expertise aligns with bioinformatics methods and diabetes context.
- Request additional statistical review when complex models are used.
- Ensure reviewer feedback addresses data quality and validation.
- Encourage authors to clarify cohort definitions and exclusions.
- Check that data availability statements are complete and accurate.
- Monitor review timelines and send reminders as needed.
- Assess whether conclusions match the evidence presented.
- Flag potential ethical concerns or conflicts promptly.
- Recommend revisions for unclear computational workflows.
- Verify that code or pipeline documentation is adequate.
- Promote balanced reviewer feedback and avoid bias.
- Encourage transparency in reporting limitations.
- Use standard decision templates to maintain consistency.
- Check for compliance with journal formatting requirements.
- Ensure revisions address reviewer comments comprehensively.
- Escalate cases of suspected plagiarism or data issues.
- Document decision rationale in the editorial system.
- Provide authors with clear, actionable decision letters.
- Encourage reviewers to comment on model interpretability and clinical impact.
- Confirm that peer review comments are respectful and professional.
JBD is committed to rigorous, transparent publishing in bioinformatics and diabetes research. We emphasize reproducible computational methods, clear data provenance, and ethical compliance across all article types.
The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].
We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in computational and translational diabetes research.
Interested in Serving as an Editor?
Join the JBD editorial team to guide high impact research.